These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 10077777

  • 1. Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
    Johnson PA, Rodriguez HP, Wazen JJ, Huck W, Shan M, Tosiello R, Heyd A, Echols RM.
    J Otolaryngol; 1999 Feb; 28(1):3-12. PubMed ID: 10077777
    [Abstract] [Full Text] [Related]

  • 2. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
    Klein GL, Whalen E, Echols RM, Heyd A.
    J Otolaryngol; 1998 Feb; 27(1):10-6. PubMed ID: 9511113
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
    Siegert R, Berg O, Gehanno P, Leiberman A, Martinkenas JL, Nikolaidis P, Arvis P, Alefelder M, Reimnitz P.
    Eur Arch Otorhinolaryngol; 2003 Apr; 260(4):186-94. PubMed ID: 12709801
    [Abstract] [Full Text] [Related]

  • 4. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.
    Burke T, Villanueva C, Mariano H, Huck W, Orchard D, Haverstock D, Heyd A, Church D.
    Clin Ther; 1999 Oct; 21(10):1664-77. PubMed ID: 10566563
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
    Siegert R, Gehanno P, Nikolaidis P, Bagger-Sjöbäck D, Ibanez JM, Hampel B, Sommerauer B.
    Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431
    [Abstract] [Full Text] [Related]

  • 6. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis.
    Camacho AE, Cobo R, Otte J, Spector SL, Lerner CJ, Garrison NA, Miniti A, Mydlow PK, Giguere GC, Collins JJ.
    Am J Med; 1992 Sep; 93(3):271-6. PubMed ID: 1524078
    [Abstract] [Full Text] [Related]

  • 7. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, McCarty J, Farkas S, Drehobl M, Tosiello R, Shan M, Aneiro L, Kowalsky S.
    Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
    [Abstract] [Full Text] [Related]

  • 8. Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis.
    Sydnor A, Gwaltney JM, Cocchetto DM, Scheld WM.
    Arch Otolaryngol Head Neck Surg; 1989 Dec; 115(12):1430-3. PubMed ID: 2510772
    [Abstract] [Full Text] [Related]

  • 9. Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis.
    Stefansson P, Jacovides A, Jablonicky P, Sedani S, Staley H.
    Rhinology; 1998 Dec; 36(4):173-8. PubMed ID: 9923060
    [Abstract] [Full Text] [Related]

  • 10. Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis.
    Henry DC, Sydnor A, Settipane GA, Allen J, Burroughs S, Cobb MM, Holley HP.
    Clin Ther; 1999 Jul; 21(7):1158-70. PubMed ID: 10463514
    [Abstract] [Full Text] [Related]

  • 11. Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group.
    Gehanno P, Berche P.
    J Antimicrob Chemother; 1996 May; 37 Suppl A():105-14. PubMed ID: 8737130
    [Abstract] [Full Text] [Related]

  • 12. Telithromycin for the treatment of acute bacterial maxillary sinusitis: a review of a new antibacterial agent.
    Tellier G, Brunton SA, Nusrat R.
    South Med J; 2005 Sep; 98(9):863-8. PubMed ID: 16217977
    [Abstract] [Full Text] [Related]

  • 13. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
    Shah PM, Maesen FP, Dolmann A, Vetter N, Fiss E, Wesch R.
    J Antimicrob Chemother; 1999 Apr; 43(4):529-39. PubMed ID: 10350383
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [Abstract] [Full Text] [Related]

  • 16. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Clin Ther; 1995 Nov; 17(5):861-74. PubMed ID: 8595638
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
    File TM, Segreti J, Dunbar L, Player R, Kohler R, Williams RR, Kojak C, Rubin A.
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
    [Abstract] [Full Text] [Related]

  • 18. Cefuroxime axetil in the treatment of sinusitis. A review.
    Pakes GE, Graham JA, Rauch AM, Collins JJ.
    Arch Fam Med; 1994 Feb; 3(2):165-75. PubMed ID: 7994439
    [Abstract] [Full Text] [Related]

  • 19. [Efficiency of a four-day course of pristinamycin compared to a five-day course of cefuroxime axetil for acute bacterial maxillary sinusitis in adult outpatients].
    Gehanno P, Berche P, Hercot O, d'Arras L, Cabrillac-Rives S, Derobert E, Choné C.
    Med Mal Infect; 2004 Jul; 34(7):293-302. PubMed ID: 15679233
    [Abstract] [Full Text] [Related]

  • 20. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J, Profant M, Kostrica R, Waskin H.
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.